Impact News +++ Hugo-Boss-Grossaktionär hält nichts von Dividenden (Cash) +++ HUGO BOSS Aktie +4,81%

TELO GENOMICS Aktie

>TELO GENOMICS Aktienkurs

0.072 EUR (Tradegate)

Ask: 0.0755 EUR / 26491 Stück

Bid: 0.0685 EUR / 29283 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>TELO GENOMICS Performance

1 Woche: +7,2%

1 Monat: +29,8%

3 Monate: +7,2%

6 Monate: -14,2%

1 Jahr: -46,8%

laufendes Jahr: -11,6%

>TELO GENOMICS Aktie

Name:

TELO GENOMICS CORP. O.N.

Land:

Kanada

Sektor:

Gesundheit

ISIN/ Wkn:

CA87975M2085 / A2PV0Q

Symbol/ Ticker:

3D0A (Frankfurt)

Kürzel:

FRA:3D0A, ETR:3D0A, 3D0A:GR

Index:

Webseite:

https://www.telodx.com/

Marktkapitalisierung:

4.8 Mio. EUR

Umsatz:

EBITDA:

-2.25 Mio. EUR

Gewinn je Aktie:

-0.017 EUR

Schulden:

Liquide Mittel:

1.08 Mio. EUR

Umsatz-/ Gewinnwachstum:

- / -

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

- / 3.49 / -

Gewinnm./ Eigenkapitalr.:

- / -303.19%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

TELO GENOMICS

Letzte Datenerhebung:

04.07.25

>Eigentümer

Aktien: 100.02 Mio. St.

f.h. Aktien: 96 Mio. St.

Insider Eigner: 3.9%

Instit. Eigner: 2.06%

Leerverk. Aktien: -

>Peer Group

AYURCANN

BIG PHARMA SPLIT

CHRISTINA LAKE CANNABIS

DENTALCORP

FLORA GROWTH

HERBAL DISPATCH

NEXTLEAF

PHARMADRUG

SIRONA BIOCHEM

UNIVERSAL IBOGAINE

>TELO GENOMICS Chart & Kurs - Tradegate

>TELO GENOMICS News

01.07.25 - 00:54	Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the......

18.06.25 - 14:42	Telo Genomics Corp.: Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for h......

27.05.25 - 14:42	Telo Genomics Corp.: Telo Genomics Receives New Client Tier under Intellectual Property Ontario (IPON) (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for hum......

15.05.25 - 14:42	Telo Genomics Corp.: European Hematology Association Accepts Abstract from Telo Genomics for Presentation at The 2025 Congress (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - May 15, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for hum......

10.04.25 - 14:42	Telo Genomics Corp.: Telo Genomics Announces Acceptance of its MRD Validation Data in Multiple Myeloma for ASCO 2025 (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for ......

04.04.25 - 14:42	Telo Genomics Corp.: Telo Genomics Announces Appointment of John Farlinger to Its Board of Directors (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - April 4, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tes......

12.03.25 - 13:45	Telo Genomics appoints Baechler executive chairman of the board of directors (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.03.25 - 13:42	Telo Genomics Corp.: Telo Genomics Appoints Baechler Executive Chairman of The Board of Directors (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic te......

27.02.25 - 14:42	Telo Genomics Corp.: Telo Genomics Announces Expanded Partnership with Trusted Health Advisors (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that, further to its engagement with Trusted H......

23.12.24 - 22:06	Telo Genomics Corp.: Telo Genomics Closes Oversubscribed $2.5 Million Private Placement (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce that, further to its news rele......

12.12.24 - 14:54	Telo Genomics Corp.: Telo Genomics Announces Private Placement for up to $2 Million (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - December 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce a non-brokered private placeme......

19.11.24 - 14:55	Telo Genomics Corp.: Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON) (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere tech......

30.10.24 - 13:55	Telo Genomics Corp.: Telo Genomics Expands its Strategic Collaboration with Mayo Clinic (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - October 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere techn......

22.10.24 - 14:54	Telo Genomics Corp.: Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere techn......

10.09.24 - 14:54	Telo Genomics Corp.: Telo Genomics Assessing MRD Status in TELO-DMRD Study (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere tec......

13.08.24 - 15:01	Telo Genomics Corp.: Telo Genomics Receives CLIA Certification (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere techno......

18.06.24 - 14:55	Telo Genomics Corp.: Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technolo......

12.06.24 - 14:55	Telo Genomics Corp.: Telo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024 (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, ......

30.05.24 - 14:54	Telo Genomics Corp.: Telo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), a biotech company developing the industry's leading telo......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Im Winter beim Ofen, im Sommer im Feld. - Bauernregel - Bauernweisheit

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram